Delivery Order SPE2DX22D0010-SPE2D826FCG10
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 7, 2026, valued at $21,483.00 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside award is scheduled for completion by January 8, 2026, with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order execution under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $93,276.40 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $6,156.96 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $8,771.85 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The work...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $928K by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, the company's corporate headquarters location. The delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the DLA...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCG10Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $34,593.82 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. Amerisourcebergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical supplies to support military healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to compete successfully in open competition and fulfill federal medical procurement requirements reflects its critical role as a prime vendor within the Defense Logistics Agency's pharmaceutical supply chain, serving military treatment facilities, the Defense Health Agency, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.6k | 1/6/26 |